Oniria Therapeutics

Oniria Therapeutics

Innovative treatment for cancer using advanced therapy to modulate cell dormancy, leading to better outcomes and a potential cure. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€5—8m (Dealroom.co estimates May 2023.)
Company register number B67943647
Barcelona Catalonia (HQ)
Authorizing premium user...